99 related articles for article (PubMed ID: 10084154)
1. [Synthesis of substituted benzoylacrylic acids as potential antagonists of phospholipase A2].
Nuhn P; Herrmann A; Radman M
Pharmazie; 1999 Feb; 54(2):93-8. PubMed ID: 10084154
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of benzoyl phenyl benzoates as effective inhibitors for phospholipase A2 and hyaluronidase enzymes.
Khanum SA; Murari SK; Vishwanth BS; Shashikanth S
Bioorg Med Chem Lett; 2005 Sep; 15(18):4100-4. PubMed ID: 15993585
[TBL] [Abstract][Full Text] [Related]
3. Specific binding of non-steroidal anti-inflammatory drugs (NSAIDs) to phospholipase A2: structure of the complex formed between phospholipase A2 and diclofenac at 2.7 A resolution.
Singh N; Jabeen T; Sharma S; Somvanshi RK; Dey S; Srinivasan A; Singh TP
Acta Crystallogr D Biol Crystallogr; 2006 Apr; 62(Pt 4):410-6. PubMed ID: 16552142
[TBL] [Abstract][Full Text] [Related]
4. Phospholipase A2 genes and their expressions in Thai Russell's viper venom glands.
Sai-Ngam A; Phongtananant S; Nuchprayoon I
Toxicon; 2008 Aug; 52(2):395-9. PubMed ID: 18602940
[TBL] [Abstract][Full Text] [Related]
5. Structural basis of phospholipase A2 inhibition for the synthesis of prostaglandins by the plant alkaloid aristolochic acid from a 1.7 A crystal structure.
Chandra V; Jasti J; Kaur P; Srinivasan A; Betzel Ch; Singh TP
Biochemistry; 2002 Sep; 41(36):10914-9. PubMed ID: 12206661
[TBL] [Abstract][Full Text] [Related]
6. Crystallization and preliminary X-ray diffraction studies of the neurotoxic, heterodimeric phospholipase A2 from the Taiwan viper (Vipera russelli formosensis).
Rajashankar KR; Tsai IH; Betzel C
Acta Crystallogr D Biol Crystallogr; 1999 May; 55(Pt 5):1064-5. PubMed ID: 10216307
[TBL] [Abstract][Full Text] [Related]
7. [Synthesis of lipophilic keto acids by acylation of alkylbenzenes as potential inhibitors of phospholipase A2].
Nuhn P; Radman M; Hermann A; Marx K
Pharmazie; 1998 Dec; 53(12):825-9. PubMed ID: 10189306
[No Abstract] [Full Text] [Related]
8. Inhibition of mediator release from anaphylactic guinea pig hearts by the novel phospholipase A2 inhibitor 3-(4-octadecylbenzoyl) acrylic acid.
Abate A; Giessler J; Giessler C; Pönicke K; Hirschelmann R; Nuhn P
Inflamm Res; 1997 Aug; 46 Suppl 2():S137-8. PubMed ID: 9297549
[No Abstract] [Full Text] [Related]
9. Phospholipase A2 inhibition by alkylbenzoylacrylic acids.
Köhler T; Friedrich G; Nuhn P
Agents Actions; 1991 Jan; 32(1-2):70-2. PubMed ID: 2058477
[No Abstract] [Full Text] [Related]
10. Design of specific peptide inhibitors of phospholipase A2: structure of a complex formed between Russell's viper phospholipase A2 and a designed peptide Leu-Ala-Ile-Tyr-Ser (LAIYS).
Chandra V; Jasti J; Kaur P; Dey S; Srinivasan A; Betzel Ch; Singh TP
Acta Crystallogr D Biol Crystallogr; 2002 Oct; 58(Pt 10 Pt 2):1813-9. PubMed ID: 12351825
[TBL] [Abstract][Full Text] [Related]
11. Effects of phospholipase A2 and metalloprotease fractions of Russell's viper venom on cytokines and renal hemodynamics in dogs.
Mitrmoonpitak C; Chulasugandha P; Khow O; Noiprom J; Chaiyabutr N; Sitprija V
Toxicon; 2013 Jan; 61():47-53. PubMed ID: 23142505
[TBL] [Abstract][Full Text] [Related]
12. Modeling studies on phospholipase A2-inhibitor complexes.
Nirmal N; Praba GO; Velmurugan D
Indian J Biochem Biophys; 2008 Aug; 45(4):256-62. PubMed ID: 18788476
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of in vivo anticoagulant and haemolytic activity by a neutral phospholipase A(2) purified from Daboia russelii russelii venom: correlation with clinical manifestations in Russell's Viper envenomed patients.
Saikia D; Majumdar S; Mukherjee AK
Toxicon; 2013 Dec; 76():291-300. PubMed ID: 24125661
[TBL] [Abstract][Full Text] [Related]
14. [Studies on antiallergy agent. II. Synthesis of 3-benzoylacrylic acids and the related compounds].
Ozeki K; Ishizuka Y; Sawada M; Shimamura H; Ichikawa T; Sato M; Yaginuma H
Yakugaku Zasshi; 1987 Apr; 107(4):268-73. PubMed ID: 3656087
[No Abstract] [Full Text] [Related]
15. (E)-Phenyl- and -heteroaryl-substituted O-benzoyl-(or acyl)oximes as lipoprotein-associated phospholipase A2 inhibitors.
Jeong TS; Kim MJ; Yu H; Kim KS; Choi JK; Kim SS; Lee WS
Bioorg Med Chem Lett; 2005 Mar; 15(5):1525-7. PubMed ID: 15713421
[TBL] [Abstract][Full Text] [Related]
16. In silico identification of viper phospholipaseA2 inhibitors: validation by in vitro, in vivo studies.
Nargotra A; Sharma S; Alam MI; Ahmed Z; Bhagat A; Taneja SC; Qazi GN; Koul S
J Mol Model; 2011 Dec; 17(12):3063-73. PubMed ID: 21360175
[TBL] [Abstract][Full Text] [Related]
17. Antibacterial potential of a basic phospholipase A2 (VRV-PL-V) of Daboia russellii pulchella (Russell's Viper) venom.
Sudarshan S; Dhananjaya BL
Biochemistry (Mosc); 2014 Nov; 79(11):1237-44. PubMed ID: 25540009
[TBL] [Abstract][Full Text] [Related]
18. Phospholipase A2 inhibition by alkylbenzoylacrylic acids.
Köhler T; Heinisch M; Kirchner M; Peinhardt G; Hirschelmann R; Nuhn P
Biochem Pharmacol; 1992 Aug; 44(4):805-13. PubMed ID: 1324685
[TBL] [Abstract][Full Text] [Related]
19. A major phospholipase A2 from Daboia russelii russelii venom shows potent anticoagulant action via thrombin inhibition and binding with plasma phospholipids.
Mukherjee AK
Biochimie; 2014 Apr; 99():153-61. PubMed ID: 24333043
[TBL] [Abstract][Full Text] [Related]
20. Phospholipase A2 activation is not required for long-term synaptic depression.
Stanton PK
Eur J Pharmacol; 1995 Feb; 273(3):R7-9. PubMed ID: 7737325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
